Qu Biologics Inc.

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• HGHarold GunnDirector · Executive Officer
• MLMichael LeschukDirector
• JLJulia LevyDirector
• JPJim PankovichExecutive Officer
• RPRobert PelzerDirector
• ARAlun ReesExecutive Officer
• SSSimon SutcliffeDirector · Executive Officer
• GVGillian VandermeirschExecutive Officer

• 23 Apr 2026Innate Targeting of Adoptive Cellular Therapiesapplication
• 09 Dec 2025Innate Targeting of Adoptive Cellular Therapiesgranted
• 13 Jun 2024Personalized Site-Specific Immunomodulationapplication
• 21 Mar 2024Perioperative Innate Immune Priming in Cancer Therapyapplication
• 21 Mar 2024Anti-Microbial Immunomodulationapplication
• 21 Nov 2023Anti-Microbial Immunomodulationgranted
• 28 Jul 2022Therapeutically Triggering an Innate Immune Response in a Target Tissueapplication
• 18 Jan 2022Therapeutically Triggering an Innate Immune Response in a Target Tissuegranted
• 16 Mar 2021Anti-Microbial Immunomodulationgranted
• 23 Apr 2020Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancersapplication
• 16 Apr 2020Personalized Site-Specific Immunomodulationapplication
• 09 Apr 2019Anti-microbial Immunomodulationgranted

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.